Nusayba Bagegni

3PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 21, 2025
Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer.

Foluso O Ademuyiwa, Cynthia X Ma, Katherine Weilbaecher

|Jun 02, 2023
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer.

Whitney L Hensing, Lorenzo Gerratana, Katherine Clifton

|May 06, 2022
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab.

Nusayba A Bagegni, Andrew A Davis, Katherine K Clifton

Pageof 1